Independent guide • Anticipated launch July 1, 2026

Understand the Medicare GLP-1 Bridge program

A plain-English guide to who qualifies, which medications are covered, what you'll pay, and how to get approved — built for Medicare members and their families.

Sources cited from CMS.gov & FDA.gov

Is this program for you?

  • You're enrolled in Medicare Part D
  • You have a qualifying health condition
  • You take or want a GLP-1 medication
Start the 5-question check

Free • No sign-up • Takes about 1 minute

The Medicare GLP-1 Bridge program is a coverage pathway designed to help eligible Medicare beneficiaries access GLP-1 medications — such as Wegovy, Zepbound, and Ozempic — through their Part D drug plans. Historically, Medicare did not cover these drugs for weight loss alone, but coverage has expanded for qualifying conditions. This site walks you through eligibility, costs, covered medications, and the prior-authorization process in clear language.

Start with the right tool

Four free tools to help you understand your coverage and options.

How the Bridge program works

  1. Confirm your Medicare Part D enrollment. Bridge coverage runs through Part D drug plans (standalone or via Medicare Advantage).
  2. Document a qualifying condition. Coverage is tied to conditions such as type 2 diabetes or a recognized cardiovascular indication.
  3. Get a prescription and prior authorization. Your prescriber submits a prior-authorization request to your plan.
  4. Fill at an in-network pharmacy. Once approved, your covered copay applies instead of the full retail price.

Explore your coverage

Not sure where to begin?

Take the free 5-question eligibility check. It's the fastest way to understand your situation under the new Bridge rules.

Check my eligibility →

Disclaimer: GLP1Bridge.com is an independent informational resource and is not affiliated with, endorsed by, or operated by Medicare, CMS, or any drug manufacturer. Content is for general education only and is not medical, legal, or financial advice. Always confirm coverage details with your plan and consult a licensed professional. Sources: CMS.gov, FDA.gov.